Healthy Life Agritec rights issue: up to ₹50 crore in 2026

What the board approved on September 23, 2026

Healthy Life Agritec’s board has approved raising funds through a rights issue of up to ₹50 crore. The decision was taken at a Board of Directors meeting held on September 23, 2026. The company said the issuance will be through partly paid-up equity shares. Each share will carry a face value of ₹10.

The company has not finalised the detailed terms of the issue yet. It said key items such as the record date and issue price are still to be determined. Any fund raise will also be subject to applicable regulatory approvals.

Rights issue structure: partly paid-up equity shares

The rights issue is proposed in the form of equity shares that are partly paid-up, as disclosed in the company’s update. Partly paid-up shares generally mean shareholders pay the issue price in instalments as per a schedule set by the issuer. The article does not provide a payment schedule or the portion payable upfront.

The face value is stated as ₹10 per share. Beyond this, the company has not disclosed how many shares it plans to issue or the rights entitlement ratio for the new fund raise. Those details are expected once the final terms are approved.

Key disclosed terms at a glance

The lead-up: board meeting notice and trading window closure

Healthy Life Agritec had scheduled the September 23, 2026 board meeting to consider raising funds through equity shares or other securities. The proposed route included a rights issue or any other permissible mode. The company indicated the process would be subject to regulatory approvals.

It also disclosed compliance steps around insider trading norms. The trading window for insiders was to remain closed from the next trading day after the September 19 intimation until 48 hours after the board meeting concluded. The article does not mention when the window re-opened.

Context: an earlier rights issue raised ₹24.81 crore

The latest approval comes after Healthy Life Agritec previously raised ₹24.81 crore through a rights issue during FY26, according to the article. The company allotted 2.48 million (2,48,12,000) equity shares at ₹10 per share. The stated utilisation of proceeds was for working capital requirements and general corporate purposes.

The article also notes a disclosure that, during Q3FY26, the company raised ₹24.812 crore by issuing 2,48,12,000 equity shares at an issue price of ₹10 per share. These figures align with the earlier rights issue size described.

What changed in the equity base after the 2025 allotment

Healthy Life Agritec completed the allotment of 2,48,12,000 equity shares through the rights issue at ₹10 per share, as per the article. The Rights Issue Committee approved the allotment to eligible equity shareholders and renouncees. The company’s paid-up equity share capital increased from ₹24.812 crore to ₹49.624 crore, effectively doubling.

The allotment approval is linked in the article to a Rights Issue Committee meeting dated November 3, 2025, based on LODR data. The article also states that the allotment was approved in consultation with Cameo Corporate Services Limited and BSE Limited.

Promoter holding update linked to the completed issue

The company disclosed that promoters Divya Mojjada and Cronos Global Investments Holdings Private Limited increased their combined shareholding to 28.86% through the rights issue completed on November 3, 2025. The article does not provide the promoter holding before the increase or the exact number of shares subscribed by the promoters.

This data point matters because rights issues can change ownership percentages depending on participation levels by promoters and public shareholders. The article does not quantify the overall subscription level of the earlier issue.

2025 record date and issue schedule details cited in the article

The article contains multiple dated references for the earlier rights issue. It states a record date of 26-Sep-2025, and also mentions a subscription period of 10-09-2025 to 26-09-2025. Separately, it also states the rights issue was to open on October 7, 2025 and close on October 31, 2025, with the record date again stated as September 26, 2025.

The same section also lists operational dates such as the “last date to buy shares” as September 25, 2025 and a deemed date of allotment as October 3, 2025. These are presented in the article as part of the earlier issue’s timeline.

Capital structure: authorised capital expansion mentioned

The article notes that the company increased its authorised share capital to ₹50 crore. It also provides a capital-structure table showing a proposed authorised capital increase from ₹50 crore to ₹100 crore, described as a 100% increase, with the number of shares doubling from 5 crore to 10 crore shares (face value unchanged at ₹10).

The article does not explicitly link this proposed authorised capital change to the September 23, 2026 board approval, but it presents it as part of the rights-issue related disclosures.

Market impact and what investors should track next

The immediate disclosed impact is corporate action clarity: the board has approved a rights issue size ceiling of ₹50 crore, but the company has not yet set the issue price, record date, or final structure. Until those terms are announced, investors typically have limited information to assess dilution, entitlement, and cash outlay.

For shareholders, the next set of disclosures to watch would include the final terms of the rights issue, including the record date, issue price, entitlement ratio, and payment schedule given the partly paid-up nature of the proposed shares. The company has already indicated that the issue will be subject to regulatory approvals, implying further filings and exchange updates should follow.

Summary

Healthy Life Agritec’s board has approved raising up to ₹50 crore via a rights issue of partly paid-up equity shares with a face value of ₹10, while key commercial terms are yet to be finalised. The company’s earlier rights issue raised ₹24.81 crore at ₹10 per share and doubled paid-up equity share capital. The next milestones, as per the company’s disclosure framework, are the announcement of record date, issue price, and other final terms, along with any required regulatory and exchange filings.